AI assistant
BIOGEN INC. — Director's Dealing 2011
Jan 5, 2011
30291_dirs_2011-01-05_a5e2b17d-a04c-4f55-a6e5-cd7275cb3780.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2011-01-04
Reporting Person: Gagnon Robert E. (Chief Acct Officer VP & Contr)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-01-04 | Common Stock | S | 796 | $66.5697 | Disposed | 10814 | Direct |
| 2011-01-04 | Common Stock | M | 1554 | $49.59 | Acquired | 12368 | Direct |
| 2011-01-04 | Common Stock | S | 1554 | $66.5762 | Disposed | 10814 | Direct |
| 2011-01-04 | Common Stock | M | 1700 | $40.63 | Acquired | 12514 | Direct |
| 2011-01-04 | Common Stock | S | 1700 | $66.5535 | Disposed | 10814 | Direct |
| 2011-01-04 | Common Stock | M | 1053 | $49.65 | Acquired | 11867 | Direct |
| 2011-01-04 | Common Stock | S | 1053 | $66.5723 | Disposed | 10814 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-01-04 | Stock Option (Right to Buy) | $49.59 | M | 1554 | Disposed | 2018-10-01 | Common Stock (1554) | Direct |
| 2011-01-04 | Stock Option (Right to Buy) | $40.63 | M | 1700 | Disposed | 2015-10-31 | Common Stock (1700) | Direct |
| 2011-01-04 | Stock Option (Right to Buy) | $49.65 | M | 1053 | Disposed | 2019-02-24 | Common Stock (1053) | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F3: This represents the weighted average price for shares sold at a range between $66.33 (low) $66.91 (high).
F4: This represents the weighted average price for shares sold at a range between $66.35 (low) $67.00 (high).
F5: This represents the weighted average price for shares sold at a range between $66.33 (low) $67.00 (high).
F6: This represents the weighted average price for shares sold at a range between $66.33 (low) $66.98 (high).
F7: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F8: The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 10/01/2008.
F9: The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 10/31/2005.
F10: The stock options become exercisable in four (4) equal annual installments commencing one year after the grant date of 02/24/09.